ZELLENPENETRIERENDE PEPTIDE
European patent · EP3908322 · In force
Register entry
- Publication number
- EP3908322
- Application number
- EP20700375
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 10, 2020
- Published
- Nov 17, 2021
- Granted
- Aug 26, 2026
- Protection ends at the latest
- Jan 9, 2040
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 47/54 (2017.01)A61K 47/64 (2017.01)C12N 15/11 (2006.01)C12N 15/87 (2006.01)
- Priority
- GB 201900443 11.01.2019
- PCT application
- PCT/EP2020/050524 10.01.2020
- PCT publication
- WO2020/144317 16.07.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 26, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 26.08.2026
Parties
Holder
vectiopep OÜ
61702 Külitse alevik, Kambja vald, Tartu maakond, EE
Inventor
ARUKUUSK, Piret
51006 Tartu, EE
LANGEL, Ülo
51004 Tartu, EE
POROSK, Ly
50113 Tartu, EE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.